Clinical Trial
doi: 10.1016/s0035-9203(00)90131-7.
Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study
Affiliations
- PMID: 11127251
- DOI: 10.1016/s0035-9203(00)90131-7
Item in Clipboard
Clinical Trial
Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study
Trans R Soc Trop Med Hyg.
2000 Jul-Aug.
No abstract available
Similar articles
-
Injectable paromomycin for Visceral leishmaniasis in India.N Engl J Med. 2007 Jun 21;356(25):2571-81. doi: 10.1056/NEJMoa066536. N Engl J Med. 2007. PMID: 17582067 Clinical Trial.
-
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.Lancet. 2011 Feb 5;377(9764):477-86. doi: 10.1016/S0140-6736(10)62050-8. Epub 2011 Jan 20. Lancet. 2011. PMID: 21255828 Clinical Trial.
-
Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study.PLoS Negl Trop Dis. 2010 Oct 26;4(10):e855. doi: 10.1371/journal.pntd.0000855. PLoS Negl Trop Dis. 2010. PMID: 21049063 Free PMC article. Clinical Trial.
-
Amphotericin B for treatment of visceral leishmaniasis: systematic review and meta-analysis of prospective comparative clinical studies including dose-ranging studies.Clin Microbiol Infect. 2018 Jun;24(6):591-598. doi: 10.1016/j.cmi.2017.11.008. Epub 2017 Nov 11. Clin Microbiol Infect. 2018. PMID: 29138100 Review.
-
Visceral leishmaniasis: elimination with existing interventions.Lancet Infect Dis. 2011 Apr;11(4):322-5. doi: 10.1016/S1473-3099(10)70320-0. Lancet Infect Dis. 2011. PMID: 21453873 Review.
Cited by
-
A Targeted and Protease-Activated Genetically Encoded Melittin-Containing Particle for the Treatment of Cutaneous and Visceral Leishmaniasis.ACS Appl Mater Interfaces. 2024 Sep 18;16(37):49148-49163. doi: 10.1021/acsami.4c10426. Epub 2024 Sep 6. ACS Appl Mater Interfaces. 2024. PMID: 39240583 Free PMC article.
-
Identification of Potential Kinase Inhibitors within the PI3K/AKT Pathway of Leishmania Species.Biomolecules. 2021 Jul 16;11(7):1037. doi: 10.3390/biom11071037. Biomolecules. 2021. PMID: 34356660 Free PMC article.
-
Towards elimination of visceral leishmaniasis in the Indian subcontinent-Translating research to practice to public health.PLoS Negl Trop Dis. 2017 Oct 12;11(10):e0005889. doi: 10.1371/journal.pntd.0005889. eCollection 2017 Oct. PLoS Negl Trop Dis. 2017. PMID: 29023446 Free PMC article. Review.
-
Efficacy and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis in Children and Adolescents at a Tertiary Care Center in Bihar, India.Am J Trop Med Hyg. 2017 Nov;97(5):1498-1502. doi: 10.4269/ajtmh.17-0094. Epub 2017 Oct 10. Am J Trop Med Hyg. 2017. PMID: 29016288 Free PMC article.
-
The Role of Natural Products in Drug Discovery and Development against Neglected Tropical Diseases.Molecules. 2016 Dec 31;22(1):58. doi: 10.3390/molecules22010058. Molecules. 2016. PMID: 28042865 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
